These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5826083)

  • 21. Relations between polymorphisms in drug-metabolising enzymes and toxicity of chemotherapy with cyclophosphamide, thiotepa and carboplatin.
    Ekhart C; Rodenhuis S; Smits PH; Beijnen JH; Huitema AD
    Pharmacogenet Genomics; 2008 Nov; 18(11):1009-15. PubMed ID: 18854779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy, feasibility, and clinical impact of prospective Bayesian pharmacokinetically guided dosing of cyclophosphamide, thiotepa, and carboplatin in high-dose chemotherapy.
    de Jonge ME; Huitema AD; Tukker AC; van Dam SM; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2005 Jan; 11(1):273-83. PubMed ID: 15671556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclophosphamide in Landry-Guillain-Barré syndrome.
    Ahuja GK; Mohandas S; Virmani V
    Acta Neurol (Napoli); 1980 Jun; 2(3):186-90. PubMed ID: 7415884
    [No Abstract]   [Full Text] [Related]  

  • 24. [Results of a cooperative therapy study with cyclophosphamide and roentgen rays of malignant tumors in childhood].
    Neidhardt M
    Monatsschr Kinderheilkd (1902); 1970 Jun; 118(6):304-5. PubMed ID: 5523667
    [No Abstract]   [Full Text] [Related]  

  • 25. [Compatibility and action of very high dosage of endoxuan in the treatment of tumors].
    Martini H; Scheef W; Knecht B
    Med Welt; 1967 Jul; 26():1573-8. PubMed ID: 5616188
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cytostatic attack treatment in surgery].
    Boeckl O; Karrer K
    Chirurg; 1965 Nov; 36(11):481-2. PubMed ID: 5882638
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of endoxan in malignant granuloma].
    Topolska P; Rostkowska J
    Wiad Lek; 1966 Jan; 19(2):127-30. PubMed ID: 5910345
    [No Abstract]   [Full Text] [Related]  

  • 28. [The results of endoxan application in the therapy of malignant tumors in children].
    Durnov LA; Garin AM; Platinskiĭ LV; Finogenova NA; Shkarenkov VA
    Pediatriia; 1969 May; 48(5):48-51. PubMed ID: 5809920
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase I trial of tirapazamine and cyclophosphamide in children with refractory solid tumors: a pediatric oncology group study.
    Aquino VM; Weitman SD; Winick NJ; Blaney S; Furman WL; Kepner JL; Bonate P; Krailo M; Qu W; Bernstein M
    J Clin Oncol; 2004 Apr; 22(8):1413-9. PubMed ID: 15084615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of primary cancer of the lung by means of cyclophosphamide].
    Lauria D; Liotti G; Tucci M
    Clin Ter; 1965 Sep; 34(5):415-27. PubMed ID: 5851918
    [No Abstract]   [Full Text] [Related]  

  • 31. Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: a retrospective study. Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens.
    Sládek NE; Kollander R; Sreerama L; Kiang DT
    Cancer Chemother Pharmacol; 2002 Apr; 49(4):309-21. PubMed ID: 11914911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of corticosteroid and indomethacin treatment on proteinuria].
    Michielsen P; Lambert PP
    Bull Mem Soc Med Hop Paris; 1967 Feb; 118(3):217-32. PubMed ID: 6058837
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of bronchopulmonary small cell carcinoma with a combination of cyclophosphamide and VP-16].
    González Larriba JL; Ordóñez Gallego A; Díaz Pérez MA; García de Paredes ML; Zamora P; Montero García JM
    Med Clin (Barc); 1984 May; 82(19):836-9. PubMed ID: 6330470
    [No Abstract]   [Full Text] [Related]  

  • 34. [Therapy with cyclophosphamide in O.R.L.: results in 2 cases of neoplasms of the principal respiratory tract].
    Bellomo D; Carducci A
    Arch Ital Laringol; 1965; 73(5):Suppl:105-21. PubMed ID: 5872803
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose mitoxantrone and cyclophosphamide without stem cell support in high-risk and advanced solid tumors: a phase I trial.
    Pérez-Gracia JL; Colomer R; Ruiz-Casado A; Arcediano A; Tornamira MV; Gómez-Martin C; Valentin V; Mendiola C; Cortés-Funes H; Hornedo J
    Bone Marrow Transplant; 2001 Jan; 27(2):117-23. PubMed ID: 11281378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of malignant mouth neoplasm treated conservatively].
    Betkowski A
    Wiad Lek; 1970 Mar; 23(5):411-3. PubMed ID: 5437077
    [No Abstract]   [Full Text] [Related]  

  • 37. [Middle-high dose of cyclophosphamide or conventional routine chemotherapy with increased dose of cyclophosphamide combined with G-CSF for mobilizing peripheral blood progenitor cells in patients with tumor].
    Lu DP; Liu KY; Guo NL; Shi YK; He XH; Lou FD; Da WM; Zhang BL; Wang LX; Ke XY
    Zhonghua Xue Ye Xue Za Zhi; 2003 Feb; 24(2):68-70. PubMed ID: 12697098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Good response of a paraneoplastic neuromyopathy to cyclophosphamide.
    Bruyland M; Van Belle S; Schallier D; Ebinger G; Martin JJ
    Cancer Treat Rep; 1984 May; 68(5):787-9. PubMed ID: 6327036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Malignant disorders in rheumatoid arthritis; the influence of treatment with cyclophosphamide].
    Baltus JA; Boersma JW; Vandenbroucke JP
    Ned Tijdschr Geneeskd; 1984 Feb; 128(5):205-9. PubMed ID: 6700762
    [No Abstract]   [Full Text] [Related]  

  • 40. [Studies with H3-cyclophosphamide in brain tumors. A contribution to cytostatic treatment of malignant brain tumors].
    Simon G
    Beitr Neurochir; 1966; 13():40-5. PubMed ID: 5974676
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.